Jeb Phillips

Surgical management can achieve seizure freedom in pediatric patients with drug-resistant epilepsy, but special precautions must be taken.

Genome-wide association study identifies two variants that may yield therapies for children with DMD.

Study also indicates early treatment may provide best outcomes.

With FDA approval of EpidiolexR, the pace of research on CBD medication is likely to increase.

Tests of NT-3 gene therapy on mouse models suggest potential to treat a host of muscle-wasting conditions.